Medical University of Graz: COVID-19 trials

The registry lists 11 COVID-19 studies with Medical University of Graz as lead sponsor. 0 are open to participants now and 1 have results posted.

Phase 3 1No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Posaconazole Prophylaxis for CAPA Prevention in Critically-Ill PatientsCompletedNCT05065658Results posted
• Genetics of COVID-19 Risks & Resilience in Bipolar DisorderStatus unknownNCT04972708
• Humoral and Cellular Immune Response to COVID-19 Vaccines in Immunocompromised and Healthy IndividualsCompletedNCT04858607
• Post COVID-19 Syndrome and the Gut-lung AxisCompletedNCT04813718Not applicable
• Effects of COVID-19 on Endothelium in HIV-Positive Patients in Sub-Saharan AfricaCompletedNCT04709302
• Synbiotic Therapy of Gastrointestinal Symptoms During Covid-19 InfectionCompletedNCT04420676Not applicable
• Impact of the Covid-19 Pandemic on Gastrointestinal and Liver DiseasesCompletedNCT04420637
• Psychological Impact of the Corona Virus (SARS-CoV-2) and COVID-19 Pandemic in Individuals With Psychiatric DisordersStatus unknownNCT04410835
• COVID-19 and the Developement of Phobic Fears of DiseaseStatus unknownNCT04359121
• ICU Trial in Critical Ill COVID-19 PatientsCompletedNCT04349982
• The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill PatientsActive, not recruitingNCT03188796Phase 3